Montefiore Deal to Take Over Albert Einstein College of Medicine Delayed

Yeshiva University’s Albert Einstein College of Medicine will soon be operated by Montefiore Health Systems. Image by Paul Berger
The planned takeover of Yeshiva University’s Albert Einstein College of Medicine by a Bronx hospital chain has been delayed, the Forward has learned.
Montefiore Health Systems was supposed to take over financial and operational control of Einstein on July 1.
But a spokeswoman for Montefiore said July 31 that an agreement between Y.U. and Montefiore had still not been reached.
The spokeswoman, Tracy Gurrisi, said both sides had taken “significant steps toward a final agreement” on the deal, which will see Y.U. remain as the degree-granting institution.
But, citing the “highly complex legal and regulatory” nature of the deal, Gurrisis said the two sides now hoped to finalize an agreement by September 1.
A spokesman for Y.U. released the same statement to the Forward later the same day.
Y.U. has faced annual operating deficits in the tens of millions of dollars for the past seven years. Last year’s deficit was $84 million.
Consultants brought in to stem the losses identified Einstein as being responsible for about two-thirds of those deficits.
Y.U.’s president, Richard Joel, has told staff and students that the deal to unload Einstein will significantly reduce the university’s financial problems.
Contact Paul Berger at [email protected] or on Twitter @pdberger
Did you know that only 2% of Forward readers donate to support our nonprofit newsroom? That 2% make it possible for millions to read the Forward without a paywall or subscription — removing any barriers to the full and fair Jewish story.
But while the Forward is free to read, it isn’t free to produce. Big stories — like deep dives into the antisemitism data, political scoops or reporting trips to college campuses — take months of research and fact-checking. All while we keep you informed of what you need to know each day.
— Rachel Fishman Feddersen, Forward Publisher & CEO
